Role of Inflammatory Markers and Doppler Parameters in Late-Onset Fetal Growth Restriction: A Machine-Learning Approach.


Journal

American journal of reproductive immunology (New York, N.Y. : 1989)
ISSN: 1600-0897
Titre abrégé: Am J Reprod Immunol
Pays: Denmark
ID NLM: 8912860

Informations de publication

Date de publication:
Oct 2024
Historique:
revised: 21 09 2024
received: 08 08 2024
accepted: 05 10 2024
medline: 18 10 2024
pubmed: 18 10 2024
entrez: 18 10 2024
Statut: ppublish

Résumé

This study evaluates the association of novel inflammatory markers and Doppler parameters in late-onset FGR (fetal growth restriction), utilizing a machine-learning approach to enhance predictive accuracy. A retrospective case-control study was conducted at the Department of Perinatology, Ministry of Health Etlik City Hospital, Ankara, from 2023 to 2024. The study included 240 patients between 32 and 37 weeks of gestation, divided equally between patients diagnosed with late-onset FGR and a control group. We focused on novel inflammatory markers-systemic immune-inflammation index (SII), systemic inflammatory response index (SIRI), and neutrophil-percentage-to-albumin ratio (NPAR)-and their correlation with Doppler parameters of umbilical and uterine arteries. Machine-learning algorithms were employed to analyze the data collected, including demographic, neonatal, and clinical parameters, to develop a predictive model for FGR. The machine-learning model, specifically the Random Forest algorithm, effectively integrated the inflammatory markers with Doppler parameters to predict FGR. NPAR showed a significant correlation with FGR presence, providing a robust tool in the predictive model (Accuracy 77%, area under the curve [AUC] 0.851). In contrast, SII and SIRI, while useful, did not achieve the same level of predictive accuracy (Accuracy 75% AUC 0.818 and Accuracy 73% AUC 0.793, respectively). The model highlighted the potential of combining ultrasound measurements with inflammatory markers to improve diagnostic accuracy for late-onset FGR. This study illustrates the efficacy of integrating machines with traditional diagnostic methods to enhance the prediction of late-onset FGR. Further research with a larger cohort is recommended to validate these findings and refine the predictive model, which could lead to improved clinical outcomes for affected pregnancies. ClinicalTrials.gov identifier: NCT06372938.

Identifiants

pubmed: 39422068
doi: 10.1111/aji.70004
doi:

Substances chimiques

Biomarkers 0

Banques de données

ClinicalTrials.gov
['NCT06372938']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e70004

Informations de copyright

© 2024 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Anon, “Fetal Growth Restriction: ACOG Practice Bulletin, Number 227,” Obstetrics and Gynecology 137 (2021): e16–e28.
Z. Hracsko, H. Orvos, Z. Novak, A. Pal, and I. S. Varga, “Evaluation of Oxidative Stress Markers in Neonates With Intra‐Uterine Growth Retardation,” Redox Report: Communications in Free Radical Research 13 (2008): 11.
J. A. Wixey, K. K. Chand, P. B. Colditz, and S. T. Bjorkman, “Review: Neuroinflammation in Intrauterine Growth Restriction,” Placenta 54 (2017): 117.
Y. Zhang, Z. Sheng, Q. Chen, et al., “Neutrophil Infiltration Leads to Fetal Growth Restriction by Impairing the Placental Vasculature in DENV‐Infected Pregnant Mice,” EBioMedicine 95 (2023): 104739.
Gordijn, I. M. Beune, B. Thilaganathan, et al., “Consensus Definition of Fetal Growth Restriction: A Delphi Procedure,” Ultrasound in Obstetrics & Gynecology 48 (2016): 333.
G. Rizzo, I. Mappa, V. Bitsadze, et al., “Role of Doppler Ultrasound at Time of Diagnosis of Late‐Onset Fetal Growth Restriction in Predicting Adverse Perinatal Outcome: Prospective Cohort Study,” Ultrasound in Obstetrics & Gynecology 55 (2020): 793.
X. He, F. Dai, X. Zhang, and J. Pan, “The Neutrophil Percentage‐to‐Albumin Ratio Is Related to the Occurrence of Diabetic Retinopathy,” Journal of Clinical Laboratory Analysis 36 (2022): e24334.
I. Hrubaru, A. Motoc, M. L. Moise, et al., “The Predictive Role of Maternal Biological Markers and Inflammatory Scores NLR, PLR, MLR, SII, and SIRI for the Risk of Preterm Delivery,” Journal of Clinical Medicine 11, no. 23 (2022): 6982.
C.‐C. Lan, W.‐L. Su, M.‐C. Yang, S.‐Y. Chen, and Y.‐K. Wu, “Predictive Role of Neutrophil‐Percentage‐to‐Albumin, Neutrophil‐to‐Lymphocyte and Eosinophil‐to‐Lymphocyte Ratios for Mortality in Patients With COPD: Evidence From NHANES 2011–2018,” Respirology (Carlton, Vic) 28 (2023): 1136.
X.‐N. Lv, Y.‐Q. Shen, Z.‐Q. Li, et al., “Neutrophil Percentage to Albumin Ratio Is Associated With Stroke‐Associated Pneumonia and Poor Outcome in Patients With Spontaneous Intracerebral Hemorrhage,” Frontiers in Immunology 14 (2023): 1173718.
A. Tanacan, E. Uyanik, C. Unal, and M. S. Beksac, “A Cut‐Off Value for Systemic Immune‐Inflammation Index in the Prediction of Adverse Neonatal Outcomes in Preterm Premature Rupture of the Membranes,” Journal of Obstetrics and Gynaecology Research 46 (2020): 1333.
X. Wang, J. Wang, S. Wu, Q. Ni, and P. Chen, “Association Between the Neutrophil Percentage‐to‐Albumin Ratio and Outcomes in Cardiac Intensive care unit Patients,” International Journal of General Medicine 14 (2021): 4933.
C.‐C. Wu, C.‐H. Wu, C.‐H. Lee, and C.‐I. Cheng, “Association Between Neutrophil Percentage‐to‐Albumin Ratio (NPAR), Neutrophil‐to‐Lymphocyte Ratio (NLR), Platelet‐to‐Lymphocyte Ratio (PLR) and Long‐Term Mortality in Community‐Dwelling Adults With Heart Failure: Evidence From Us NHANES 2005–2016,” BMC Cardiovascular Disorders [Electronic Resource] 23 (2023): 312.
C. C. Lees, T. Stampalija, A. A. Baschat, et al., “Isuog Practice Guidelines: Diagnosis and Management of Small‐for‐Gestational‐Age Fetus and Fetal Growth Restriction,” Ultrasound in Obstetrics & Gynecology 56 (2020): 298.
G. Ariyakumar, J. M. Morris, K. J. McKelvey, A. W. Ashton, and S. A. McCracken, “Nf‐κb Regulation in Maternal Immunity During Normal and IUGR Pregnancies,” Scientific Reports 11 (2021): 20971.
A. E. Zanno, M. A. Romer, L. Fox, et al., “Reducing th2 Inflammation Through Neutralizing Il‐4 Antibody Rescues Myelination in IUGR Rat Brain,” Journal of Neurodevelopmental Disorders 11 (2019): 34.
M. C. Sharps, B. C. Baker, T. Guevara, et al., “Increased Placental Macrophages and a Pro‐Inflammatory Profile in Placentas and Maternal Serum in Infants With a Decreased Growth Rate in the Third Trimester of Pregnancy,” American Journal of Reproductive Immunology 84 (2020): e13267.
F. Vesce, E. Cagnazzo, E. Giugliano, E. Mossuto, and R. Marci, “The Behaviour of the Peripheral Natural Killer Cells in the Foetal Growth Restriction,” European Review for Medical and Pharmacological Sciences 18 (2014): 2248.
R. Kalagiri, T. Carder, S. Choudhury, et al., “Inflammation in Complicated Pregnancy and Its Outcome,” American Journal of Perinatology 33 (2016): 1337.
T. Cotechini, W. J. Hopman, and C. H. Graham, “Inflammation‐Induced Fetal Growth Restriction in Rats Is Associated With Altered Placental Morphometrics,” Placenta 35 (2014): 575.
L. G. Greer, M. S. Ziadie, B. M. Casey, B. B. Rogers, D. D. McIntire, and K. J. Leveno, “An Immunologic Basis for Placental Insufficiency in Fetal Growth Restriction,” American Journal of Perinatology 29 (2012): 533.
F. B. Firatligil, S. T. Sucu, S. Tuncdemir, et al., “Evaluation of Systemic Immune‐Inflammation Index for Predicting Late‐Onset Fetal Growth Restriction,” Archives of Gynecology and Obstetrics 310 (2024): 433.
R. T. Ağaoğlu, “The Significance of Systemic Immune Inflammation Index (SII) and Systemic Inflammation Response Index (SIRI) in Fetuses With Fetal Growth Restriction,” Academic Journal of Health 1 (2023): 37.
S. Taner, B. Goktepe, E. I. Zaman, et al., “Role of Systemic Inflammatory Markers in Pediatric Kidney Transplantation,” Transplantation Proceedings 55 (2023): 1152.
S. Han, B. D. Williamson, and Y. Fong, “Improving Random Forest Predictions in Small Datasets From Two‐Phase Sampling Designs,” BMC Medical Informatics and Decision Making [Electronic Resource] 21 (2021): 322.

Auteurs

Can Ozan Ulusoy (CO)

Department of Perinatology, Ankara Etlik City Hospital, Ankara, Turkey.

Ahmet Kurt (A)

Department of Obstetrics and Gynecology, Ankara Etlik City Hospital, Ankara, Turkey.

Zeynep Seyhanli (Z)

Department of Perinatology, Ankara Etlik City Hospital, Ankara, Turkey.

Burak Hizli (B)

Department of Obstetrics and Gynecology, Ankara Etlik City Hospital, Ankara, Turkey.

Mevlut Bucak (M)

Department of Perinatology, Ankara Etlik City Hospital, Ankara, Turkey.

Recep Taha Agaoglu (RT)

Department of Perinatology, Ankara Etlik City Hospital, Ankara, Turkey.

Yüksel Oguz (Y)

Department of Perinatology, Ankara Etlik City Hospital, Ankara, Turkey.

Kadriye Yakut Yucel (KY)

Department of Perinatology, Ankara Etlik City Hospital, Ankara, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH